Clinical Trials Logo
  1. Home
  2. Angina, Unstable
  3. NCT00222352

Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes — Dispo-ACS  

Angina, Unstable Clinical Trial

Official title:
Diagnosis and Treatment of Acute Coronary Syndromes in the Emergency Department: The Impact of Rapid Bedside cTnI Testing on Outcomes

Clinical Trial Summary

In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial necrosis obtained in the central laboratory. Our hypothesis: point-of-care testing for troponin I will decrease the time for disposition of patients with possible ACS in the emergency setting and decrease the time required for administering appropriate therapies for these patients.

Clinical Trial Description

Cardiac troponin I is routinely used in the emergency department as a risk stratification tool for detecting myocardial necrosis in patients with possible acute coronary syndrome. It is our hypothesis that having bedside, point-of-care testing for TnI in the ED will decrease time needed to disposition patients to home from the ED or send to the cardiac catheterization laboratory or intensive care setting. Similarly, having point-of-care testing in the ED should decrease the time required to deliver anti-platelet drugs such as aspirin and glycoprotein IIb/IIIa inhibitors and anti-thrombin agents such as heparin to high risk patients found to have a positive TnI test. This will be evaluated in a randomized, controlled clinical trial of 2000 patients. Half will have the test performed in the ED at the bedside (point-of-care) while the other half will receive the usual lab results obtained from the central lab (typically requiring 1.5-2 hours to return). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00222352
Study type Observational
Source University of Cincinnati
Contact
Status Completed
Phase N/A
Start date December 2004
Completion date March 2007
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Completed NCT05466825 - Global Cardiovascular Risk Consortium
Completed NCT02290080 - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers Phase 3
Completed NCT00692991 - Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures N/A
Recruiting NCT03715582 - Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes Phase 3
Recruiting NCT02760732 - Drug Eluting Balloon for Treatment of Unstable Angina N/A
Completed NCT01331707 - DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population Phase 4
Completed NCT00091507 - IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. Phase 3
Completed NCT00269893 - A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty Phase 3
Completed NCT02983123 - One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
Recruiting NCT06075602 - COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
Completed NCT02925923 - Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel Phase 2
Completed NCT04942977 - Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy N/A
Completed NCT00354328 - Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
Completed NCT00269906 - A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty Phase 3
Completed NCT03518645 - Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds N/A
Completed NCT00133003 - Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) Phase 4
Completed NCT01617863 - Hemodynamics During the Soccer Championship 2012 N/A
Completed NCT02581540 - Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin
Completed NCT00905671 - Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study Phase 4